Welcome to The QUEST Global Initiative

The QUality of life Evaluation STudy (Global QUEST Initiative), conducted by researchers at Curtin University, aims to be the world’s largest longitudinal clinical study investigating the quality of life and health economic impact of medicinal cannabis on patients with chronic disease.

Patients accessing medicinal cannabis generally have a range of conditions and symptoms that impact their quality of life. This clinical study sets out to better understand and measure how these conditions and symptoms affect patients’ quality of life over time, as well as any ‘out of pocket’ costs, while they are accessing medicinal cannabis as a treatment option.

The Global QUEST Initiative is currently recruiting and enrolled participants will access subsidised medication as part of the study.

Find out if you’re eligible for this study

The Global QUEST Initiative is seeking eligible patients who are:

  • 18+ years of age and living in Australia
  • suffering from a chronic condition with symptoms that have lasted for three months or more
  • have tried other prescription medications that have been unsuccessful in fully treating the condition or created unwanted side effects
  • have not taken any type of prescribed medical cannabis for four weeks before enrolling in the study

Meet Dr Anita

Dr Anita Nesarajah has over 20 years’ experience and is a participating doctor in The Global QUEST Initiative, a study investigating the impact of medicinal cannabis on patients with chronic conditions.

Dr Anita is experienced working with patients who may require alternative treatments. She is empathetic, non-judgemental and compassionate. Dr Anita is fluent in Malay, Tamil and English.

Face to face appointments
IvyMed Clinic, Vermont South
Initial consult fee $200
Review consult $85

Or call QUEST 1300 664 369

Contact the QUEST Support team

Phone 1300 664 369

Please note QUEST support business hours are 9am – 5pm Australian Western Standard Time